Posted in | News | Nanomedicine | Nanomaterials

Evolution and Advancement of Nanomaterials Towards Therapeutic Drug Delivery

'Nanomaterials: Evolution and Advancement Towards Therapeutic Drug Delivery' gives the present status and future perspective of Polymeric nanoparticles, Liposomes, Carbon Nanotubes, Magnetic Nanoparticles, Silica Based nanomaterial, Hydrogels, Metallic Nanoparticles, Cyclodextrins, Poly (Lactide-Co-Glycolide) and its Copolymers.

Improvement of a vector for the delivery of therapeutic drug in a controlled and targeted fashion is still a major challenge in the treatment of many diseases. The conventional application of drugs may lead to many limitations including poor distribution, limited effectiveness, lack of selectivity and dose dependent oxicity etc.

Development of an efficient drug delivery system can surmount these problems Nanomaterials aided delivery of drug provides advantage by enhancing aqueous solubility that leads to improved bioavailability, increased resistant time in the body, decreased side effects by targeting the drug to the specific location, reduced dose dependent toxicity and protection of the drug from early release.

In this book, up-to-date studies illustrating the promising nanomaterials as drug carriers that are navigating the conventional barriers have been reported. A detailed account of various nanomaterials including polymeric nanoparticles, liposomes, dendrimers, micelles, carbon nanomaterials, magnetic nanoparticles, solid lipid-based nanoparticles, silica nanomaterials and hydrogels for drug delivery will be accounted.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.